Suzhou Highfine Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	615	361.08	1,740	99.32	78.05	92.07
Trading Asset Securities	878.62	1,346	30.76	60	45	10
Cash & Short-Term Investments	1,494	1,707	1,770	159.32	123.05	102.07
Cash Growth	-14.42%	-3.56%	1011.12%	29.48%	20.56%	23.44%
Accounts Receivable	164.63	98.34	63.56	53.42	69.11	41.76
Other Receivables	1.58	11.78	0.49	1.71	3.47	0.97
Receivables	166.21	110.12	64.05	55.12	72.58	42.73
Inventory	156	116.7	115	113.45	78.89	52.42
Other Current Assets	20.06	10.13	14.69	24.77	15.72	10.14
Total Current Assets	1,836	1,944	1,964	352.67	290.24	207.37
Property, Plant & Equipment	519.67	320.39	286.46	206.24	142.63	81.37
Other Intangible Assets	95.15	66.33	24.02	24.59	25.17	21.99
Long-Term Deferred Tax Assets	11.72	4.39	3.66	3.95	2.37	1.17
Long-Term Deferred Charges	0.51	0.1	0.08	0.26	0.29	0.16
Other Long-Term Assets	15.13	14.14	8.71	12.34	4.4	11.56
Total Assets	2,550	2,350	2,287	600.05	465.09	323.61
Accounts Payable	84.38	27.21	24.9	36.46	25.59	17.34
Accrued Expenses	17.33	17.95	16.68	23.26	15.24	8.71
Short-Term Debt	10.21	-	-	-	-	1
Current Portion of Leases	1.38	1.68	0.83	1.04	1.03	-
Current Income Taxes Payable	10.2	4.59	3.28	13.94	5.84	1.64
Current Unearned Revenue	0.79	1.38	0.61	0.6	2.34	1.02
Other Current Liabilities	57.6	18.35	19.53	34.04	34.8	27.88
Total Current Liabilities	181.89	71.16	65.84	109.33	84.84	57.59
Long-Term Leases	0.76	1.6	0.72	0.39	1.17	-
Long-Term Unearned Revenue	9.57	7.65	8.45	7.94	6.52	5.2
Long-Term Deferred Tax Liabilities	8.15	0.94	0.07	0.12	-	-
Total Liabilities	200.36	81.35	75.08	117.77	92.53	62.78
Common Stock	108	108	108	81	81	81
Additional Paid-In Capital	1,688	1,686	1,683	54.79	54.79	54.63
Retained Earnings	582.44	511.55	417.69	345.72	236.6	125.2
Treasury Stock	-33.42	-42	-	-	-	-
Comprehensive Income & Other	4.39	4.44	2.99	0.77	0.18	-
Shareholders' Equity	2,349	2,268	2,212	482.28	372.57	260.83
Total Liabilities & Equity	2,550	2,350	2,287	600.05	465.09	323.61
Total Debt	12.35	3.28	1.56	1.43	2.2	1
Net Cash (Debt)	1,481	1,704	1,769	157.9	120.85	101.07
Net Cash Growth	-15.08%	-3.66%	1020.18%	30.65%	19.58%	22.23%
Net Cash Per Share	13.74	15.76	19.12	1.95	1.50	1.25
Filing Date Shares Outstanding	106.36	106.97	108	81	81	81
Total Common Shares Outstanding	106.36	106.97	108	81	81	81
Working Capital	1,654	1,873	1,898	243.34	205.4	149.78
Book Value Per Share	22.09	21.20	20.48	5.95	4.60	3.22
Tangible Book Value	2,183	2,202	2,188	457.68	347.4	238.84
Tangible Book Value Per Share	20.52	20.58	20.26	5.65	4.29	2.95
Buildings	-	183.65	171.81	74.32	64.69	-
Machinery	-	163.79	76.02	65.92	61.8	16.04
Construction In Progress	-	21.65	72.45	87.92	28.48	74.81

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.